Want to see INKT full AI Analyst Report?
MiNK Therapeutics (INKT) Income Statement
MiNK Therapeutics Income Statement
Last quarter (Q2 2026), MiNK Therapeutics's total revenue was $0.00. In Q2, MiNK Therapeutics's net income was $-3.13M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -181.75K | $ -215.44K | $ -204.62K | $ -121.75K | $ -77.96K | |
| $ 12.31M | $ 10.43M | $ 22.72M | $ 30.83M | $ 18.53M | |
| Depreciation and Amortization | $ 181.75K | $ 215.44K | $ 204.62K | $ 121.75K | $ 77.96K |
| $ -12.31M | $ -10.57M | $ -22.25M | $ -27.87M | $ -27.70M | |
| $ -12.49M | $ -10.65M | $ -22.92M | $ -30.95M | $ -18.61M | |
| $ -6.96K | $ -134.56K | $ 463.25K | $ 2.96M | $ -11.61M | |
| $ -12.49M | $ -10.78M | $ -22.46M | $ -27.99M | $ -30.21M | |
| $ -12.49M | $ -10.78M | $ -22.46M | $ -27.99M | $ -30.21M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.93 | $ -2.90 | $ -6.54 | $ -8.31 | $ -9.03 |
| Diluted EPS | $ -2.93 | $ -2.80 | $ -6.54 | $ -8.31 | $ -9.03 |
| Weighted Average Shares Outstanding | 4.27M | 3.74M | 3.44M | 3.37M | 3.35M |
| Weighted Average Shares Outstanding (Diluted) | 4.27M | 3.86M | 3.44M | 3.37M | 3.35M |
Currency in USD